| 000 | 01645 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250518062510.0 | ||
| 264 | 0 | _c20200401 | |
| 008 | 202004s 0 0 eng d | ||
| 022 | _a0003-4509 | ||
| 024 | 7 |
_a10.1016/j.pharma.2019.07.004 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMerchaoui, S | |
| 245 | 0 | 0 |
_aOptimization of morphine extraction method for the assay of its urinary 3-glucuronideconjuguate by gas chromatography-mass spectrometry. _h[electronic resource] |
| 260 |
_bAnnales pharmaceutiques francaises _cNov 2019 |
||
| 300 |
_a468-487 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Validation Study | ||
| 650 | 0 | 4 | _a2-Propanol |
| 650 | 0 | 4 | _aAcetamides |
| 650 | 0 | 4 | _aCentrifugation |
| 650 | 0 | 4 | _aDoping in Sports |
| 650 | 0 | 4 |
_aEscherichia coli Proteins _xmetabolism |
| 650 | 0 | 4 | _aFluoroacetates |
| 650 | 0 | 4 | _aGas Chromatography-Mass Spectrometry |
| 650 | 0 | 4 |
_aGlucuronidase _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHydrogen-Ion Concentration |
| 650 | 0 | 4 | _aHydrolysis |
| 650 | 0 | 4 | _aMethyl Ethers |
| 650 | 0 | 4 | _aModels, Chemical |
| 650 | 0 | 4 |
_aMorphine _xchemistry |
| 650 | 0 | 4 |
_aMorphine Derivatives _xchemistry |
| 650 | 0 | 4 | _aSolubility |
| 650 | 0 | 4 | _aSolvents |
| 650 | 0 | 4 | _aTemperature |
| 650 | 0 | 4 | _aTrimethylsilyl Compounds |
| 650 | 0 | 4 |
_aUrinalysis _xmethods |
| 700 | 1 | _aBen Said, A | |
| 700 | 1 | _aLouati, K | |
| 700 | 1 | _aHajri, A | |
| 700 | 1 | _aSafta, F | |
| 700 | 1 | _aKallel, M | |
| 773 | 0 |
_tAnnales pharmaceutiques francaises _gvol. 77 _gno. 6 _gp. 468-487 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.pharma.2019.07.004 _zAvailable from publisher's website |
| 999 |
_c30154557 _d30154557 |
||